Jazz Pharmaceuticals plans for removal of lurbinectedin (Zepzelca) as second-line metastatic small cell lung cancer. The decision came after the confirmatory Phase 3 Lagoon trial failed on its primary endpoint of overall…
Category: Lung Cancer News
Younger Lung Cancer Patients Have More Targetable Genetic Changes
According to a large international study led in part by researchers at Sylvester Comprehensive Cancer Centre part of the University of Miami Miller School of Medicine, younger adults with non-small cell lung…
Blood Protein Signature To Predict Lung Cancer Risk Before Diagnosis
Researchers at the Francis Crick Institute and University College London, funded by Cancer Research UK and the European Research Council have identified a 14-protein signature in the blood that has the ability…
World Lung Cancer Day 2026 – Together Through Lung Cancer
The deadly disease of lung cancer affects millions of people all around the world. World Lung Cancer Day is observed annually on 1st August. It provides an opportunity to recognize progress in…
Study: Biological Sex Linked To Protein Changes In Lung Cancer
A new study from the Sanford Burnham Prebys Medical Discovery Institute has revealed that biological sex is associated with cancer incidence, its progression and drug response. It has characterized sex differences across…
American Scientists Explore New Way to Slow Down Lung Cancer
Lung Cancer remains one of the deadliest forms of cancers and is responsible for taking many lives every year all around the world. Continuous research works and studies are being conducted to…
Roche KRAS Drug, Divarasib, Showed Strong Results in Lung Cancer Treatment
Despite various advancements in treatment, lung cancer remains the leading cause of cancer-related deaths. It is responsible for claiming lives of 1.8 million people with non-small cell lung cancer accounting for about…
Lilly Launches Cancer Therapy Tanstrive (Selpercatinib) in India
Eli Lilly has launched Tanstrive (selpercatinib) in India for patients with advanced or metastatic cancers driven by alterations in the RET gene. Selpercatinib is a targeted therapy that works to block abnormal…